VSIR and leukemia: Using strategies similar to those shown in the murine cell lines, we overexpressed PD-1H in the PD-1H–negative human leukemia cell line HL-60 or knocked out PD-1H in the PD-1H–positive human leukemia cell lines MOLM14 and THP1 (Supplemental Figure 3B).